Diabetes, Vol 47, Issue 11 1748-1756, Copyright © 1998 by American Diabetes Association
Role of hyperglucagonemia in catabolism associated with type 1 diabetes: effects on leucine metabolism and the resting metabolic rate
MR Charlton and KS Nair
Endocrine Research Unit, the Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA.
The catabolic state of poorly controlled type 1 diabetes has largely been
attributed to insulin deficiency. However, the role of hyperglucagonemia,
which occurs concomitantly with insulin deficiency, has not been fully
investigated. We studied the effects of hyperglucagonemia during insulin
deprivation on energy expenditure (using indirect calorimetry) and protein
metabolism (using L-[1-(13)C,15N]leucine and L-[1-(13)C]leucine as tracers)
in 12 type 1 diabetic subjects. Five protocols were used: insulin
treatment, insulin deprivation, insulin deprivation with suppression of
endogenous glucagon with somatostatin (SRIH) and growth hormone
replacement, insulin deprivation with endogenous glucagon suppression with
SRIH (no growth hormone replacement), and insulin deprivation with SRIH and
a high level of glucagon replacement (no growth hormone replacement). It
was observed that leucine oxidation and the resting metabolic rate (RMR)
were significantly lower during insulin treatment and insulin deprivation
with concomitant SRIH infusion (lowering glucagon) than during insulin
deprivation alone. Replacement of glucagon at a high level during SRIH
infusion in the insulin-deprived state increased leucine oxidation and the
RMR. Hyperglucagonemia was also associated with a trend for decreased
protein synthesis. Hyperglucagonemia did not affect leucine transamination.
Insulin replacement decreased leucine flux and oxidation. Leucine oxidation
(R2 = 0.79) and the RMR (R2 = 0.81) were seen, by multiple regression
analysis, to correlate with glucagon levels and not with other hormones. We
conclude that while insulin deficiency increases protein breakdown,
hyperglucagonemia is primarily responsible for the increased leucine
oxidation and RMR seen during insulin deprivation.